In 2006, NattoPharma began a research partnership with the University of Maastricht, the Netherlands, the distinguished group that continues to lead the exploration of K2 discovery and its role in improving human health. This has resulted in many successes, such as partnership in the Horizon 2020 EU ITN grants EVOluTION and INTRICARE and commercial success for NattoPharma products improving human health. This renewed five-year commitment will kick-off with a research project that aims to demonstrate that vitamin K2 provides a novel solution for restoring vascular health in patients and optimizing vascular function in a healthy population.